Vimarsana
Biggest News Aggregation in the World

Eiichiro Kanda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eiichiro Kanda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eiichiro Kanda Today - Breaking & Trending Today

168th Health Research Report 16 NOV 2013 - Vimarsana News

168th Health Research Report 16 NOV 2013

168 Health Research Report WHITE PAPER /ROUGH COPY 168th Issue Date 16 NOV 2013 Compiled By Ralph Turchiano www.vit.bz www.youtube.com/vhfilm www.engineeringevil.com www.healthresearchreport.me   In this Issue: 1.      The most commonly prescribed treatment for Colds and Sore Throats offers no benefit and may actually make the illness worse 2.      Japanese super food prevents flu infection 3.      Study…

RAASi Rechallenge Uncommon After Hyperkalemia, Tied With Adverse Outcomes - Vimarsana News

RAASi Rechallenge Uncommon After Hyperkalemia, Tied With Adverse Outcomes

Investigators assessed the extent of RAASi discontinuation after a hyperkalemia episode in cardiorenal patients and its effect on hospital length of stay.

Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks - Vimarsana News

Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks

Hyperkalemia frequently results in suboptimal use of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy and cardiorenal risks.

Source: empr.com
Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks - Vimarsana News

Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks

Hyperkalemia frequently results in suboptimal use of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy and cardiorenal risks.

Potassium Binder Use Long Term Linked With Better Outcomes - Vimarsana News

Potassium Binder Use Long Term Linked With Better Outcomes

In a real-world study, investigators examined potassium binder adherence and the risk for adverse outcomes.